Company
Align Technology
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
14
510(k), De Novo and PMA
Device trials
6
As lead sponsor, any status
Adverse event reports
169
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
Align Technology is on our public-company list (ticker ALGN). Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
ALGN
Nasdaq · ALIGN TECHNOLOGY INC
Public float
$11.1B
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$4.03B
Fiscal year ending Dec 31, 2025
Net income
$410M
Fiscal year ending Dec 31, 2025
R&D spending
$370M
Fiscal year ending Dec 31, 2025
Cash
$1.14B
As of Sep 30, 2026
Long-term debt
Not reported
Shares outstanding
70.5M
As of Oct 30, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | $21.7M | – | – |
| 2024 | – | $25.3M | – | – |
| 2023 | – | $26.6M | – | – |
| 2022 | – | $26.1M | – | – |
| 2021 | – | $25.6M | – | – |
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2009 | Equity | $72.3M | $98.6M | 1 | Rule 506 | Form D ↗Aug 31, 2009 |
Company details
From the company's latest Form D.
- Legal name
- ALIGN TECHNOLOGY INC
- Headquarters
- Santa Clara, CA
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Over $100,000,000
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1097149 ↗
Executives, directors and promoters
As listed on the latest Form D.
16 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 14 since 2015.
- Invisalign System510(k)
K262196 · Decided Sep 25, 2026 · 88 days after receipt
Device type: Orthodontic Software (PNN) · Dentistry & Oral Surgery
- iTero Lumina Pro510(k)
K261847 · Decided Jul 2, 2026 · 29 days after receipt
Device type: Light Transmission Caries Detector (NTK) · Dentistry & Oral Surgery
K252931 · Decided Oct 23, 2025 · 38 days after receipt
Device type: Aligner, Sequential (NXC) · Dentistry & Oral Surgery
11 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Hyrax Vs. Invisalign Palatal Expander Clinical StudyStatus unknown
NCT06662279 · 36 participants (planned) · Start Oct 25, 2024 · Primary completion Nov 2025
Device: Removable Rapid Palatal Expander; Banded Palatal Expander · For: Malocclusions; Narrow Maxilla; Narrow Maxillary Arch and 1 more
Sites: Laguna Hills, California; Warner Robins, Georgia; Naperville, Illinois · 4 sites in all
NCT06651944 · 36 participants (planned) · Start Feb 14, 2024 · Primary completion Dec 31, 2026
Device: Invisalign® System with mandibular advancement featuring occlusal blocks · For: Class II Malocclusion; Mandibular Advancement; Mandibular Retrognathism and 1 more
Sites: Richmond, Canada; Saint John, Canada; Brampton, Canada
NCT02376829 · 164 participants · Start Mar 2015 · Primary completion Nov 23, 2021
Device: Invisalign System · For: Malocclusion
Sites: Scottsdale, Arizona; Rocklin, California; Roseville, California · 10 sites in all
3 more trials with a free account
Reports received
169
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1
0.6% of reports
Injury reports
168
99% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 7 | 0 | 0 |
| Jan 24 | 1 | 9 | 0 | 0 |
| Feb 24 | 0 | 7 | 0 | 0 |
| Mar 24 | 0 | 4 | 0 | 0 |
| Apr 24 | 0 | 7 | 0 | 0 |
| May 24 | 0 | 6 | 0 | 0 |
| Jun 24 | 0 | 7 | 0 | 0 |
| Jul 24 | 0 | 8 | 0 | 0 |
| Aug 24 | 1 | 7 | 0 | 0 |
| Sep 24 | 0 | 5 | 0 | 0 |
| Oct 24 | 0 | 11 | 0 | 0 |
| Nov 24 | 0 | 9 | 0 | 0 |
| Dec 24 | 0 | 13 | 0 | 0 |
| Jan 25 | 0 | 9 | 0 | 0 |
| Feb 25 | 0 | 12 | 0 | 0 |
| Mar 25 | 0 | 14 | 0 | 0 |
| Apr 25 | 1 | 7 | 0 | 0 |
| May 25 | 0 | 15 | 0 | 0 |
| Jun 25 | 1 | 4 | 0 | 0 |
| Jul 25 | 1 | 9 | 0 | 0 |
| Aug 25 | 0 | 9 | 0 | 0 |
| Sep 25 | 1 | 9 | 0 | 0 |
| Oct 25 | 0 | 15 | 0 | 0 |
| Nov 25 | 0 | 20 | 0 | 0 |
| Dec 25 | 1 | 26 | 0 | 0 |
| Jan 26 | 0 | 14 | 0 | 0 |
| Feb 26 | 0 | 20 | 0 | 0 |
| Mar 26 | 0 | 10 | 0 | 0 |
| Apr 26 | 0 | 10 | 0 | 0 |
| May 26 | 0 | 7 | 0 | 0 |
| Jun 26 | 0 | 12 | 0 | 0 |
| Jul 26 | 0 | 17 | 0 | 0 |
| Aug 26 | 0 | 8 | 0 | 0 |
| Sep 26 | 0 | 10 | 0 | 0 |
| Oct 26 | 0 | 14 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1017-2023 · Started Dec 5, 2022 · Posted by FDA Jan 26, 2023
Reason given: 3D orthodontic planning software has a defect that leads to an issue where incorrect number of aligners may be produced (less or greater than the doctor requested) and incorrect packaging is provided.
Cause as FDA categorized it: Software design · Device type: Orthodontic Software (PNN)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.